Miyata Akira, Miyata Kazunori, Minami Keiichiro
Miyata Eye Clinic, 4-2-34 Inokuchi, Nishi-ku, Hiroshima, 733-0842, Japan.
Miyata Eye Hospital, Miyakonojo, Japan.
Ophthalmol Ther. 2025 May 15. doi: 10.1007/s40123-025-01165-4.
This randomized prospective study aimed to quantitatively evaluate 3-year visual function, glistenings, and surface light scattering following the implantation of high-water-content hydrophobic acrylic intraocular lenses (IOLs).
One-piece high-water-content IOLs (Clareon® SY60WF; group C) and control hydrophobic acrylic IOLs (Vivinex XY1; group V) were randomly implanted in 120 Japanese participants (120 eyes). Subsequently, the corrected distance visual acuity (CDVA), contrast sensitivity, glistening-derived microvacuoles (MVs), and surface light scattering were examined up to 3 years postoperatively. EPCO software was used to confirm the absence of postoperative capsule opacification to ensure that it did not influence the outcomes. MVs within a 15 × 4 mm area were counted using a slit-lamp microscope. Surface light scattering was evaluated using densitometry. Finally, outcomes were compared among the groups.
Overall, 116 eyes were compared (58 eyes each in groups C and V). No differences in the CDVA, contrast sensitivity, and MVs were observed between the groups. The mean densitometry value in group C was significantly higher (P = 0.027) than in group V, increasing significantly from the values recorded at 1-4 weeks, although the change was clinically small (0.29%).
This randomized comparative study confirmed non-inferiority in visual function of eyes with Clareon IOLs. A 3-year comparison indicated no difference in glistening suppression, CDVA, or contrast sensitivity, whereas a slight increase was observed in surface light scattering.
Registered in the Japan Registry for Clinical Trials (identifier jRCTs032190093).
本随机前瞻性研究旨在定量评估高含水量疏水性丙烯酸人工晶状体(IOL)植入术后3年的视觉功能、晶状体闪光和表面光散射情况。
将一体式高含水量IOL(Clareon® SY60WF;C组)和对照疏水性丙烯酸IOL(Vivinex XY1;V组)随机植入120名日本受试者(120只眼)。随后,在术后3年内检查矫正远视力(CDVA)、对比敏感度、晶状体闪光衍生的微泡(MV)和表面光散射。使用EPCO软件确认术后无晶状体后囊混浊,以确保其不影响结果。使用裂隙灯显微镜对15×4mm区域内的MV进行计数。使用密度测定法评估表面光散射。最后,对各组结果进行比较。
总体上,共比较了116只眼(C组和V组各58只眼)。两组之间在CDVA、对比敏感度和MV方面未观察到差异。C组的平均密度测定值显著高于V组(P = 0.027),从1 - 4周时记录的值开始显著增加,尽管变化在临床上较小(0.29%)。
这项随机对照研究证实了使用Clareon IOL的眼睛在视觉功能上的非劣效性。3年的比较表明,在晶状体闪光抑制、CDVA或对比敏感度方面没有差异,而表面光散射略有增加。
在日本临床试验注册中心注册(标识符jRCTs032190093)。